L679-0310 Screening compound: N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

L679-0310 Screening compound: N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide
L679-0310 Screening compound: N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L679-0310
N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L679-0310

Molecular Formula

C26H27FN6O (C26 H27 FN6 O)

Compound Name

N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-4-{[3-(4-methylphenyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}piperazine-1-carboxamide

SMILES

Cc(cc1)ccc1-n1c(nccc2)c2nc1CN(CC1)CCN1C(NCc(cc1)ccc1F)=O

InChI

InChI=1S/C26H27FN6O/c1-19-4-10-22(11-5-19)33-24(30-23-3-2-12-28-25(23)33)18-31-13-15-32(16-14-31)26(34)29-17-20-6-8-21(27)9-7-20/h2-12H,13-18H2,1H3,(H,29,34)

InChI Key

PCJPSXYZEWDAHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27469097

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

458.54

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.106

Distribution Coefficient, logD

3.102

Water Solubility, LogSw

-3.02

Polar Surface Area

52.125

Acid Dissociation Constant (pKa)

14.09

Base Dissociation Constant (pKb)

5.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

L679-0310 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

PI3K-Targeted Library (17255 compounds)

PLpro Library (6343 compounds)

Epigenetics Focused Set (26518 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Targets:
  • Proteases
  • Kinases
  • Others

References: we are preparing a list of scientific research reports with L679-0310 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L679-0310?
Check Price and Availability of L679-0310, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L679-0310 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L679-0310
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L679-0310
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L679-0310 available by request